Your browser doesn't support javascript.
loading
Baclofen for the treatment of alcohol use disorder: the Cagliari Statement.
Agabio, Roberta; Sinclair, Julia Ma; Addolorato, Giovanni; Aubin, Henri-Jean; Beraha, Esther M; Caputo, Fabio; Chick, Jonathan D; de La Selle, Patrick; Franchitto, Nicolas; Garbutt, James C; Haber, Paul S; Heydtmann, Mathis; Jaury, Philippe; Lingford-Hughes, Anne R; Morley, Kirsten C; Müller, Christian A; Owens, Lynn; Pastor, Adam; Paterson, Louise M; Pélissier, Fanny; Rolland, Benjamin; Stafford, Amanda; Thompson, Andrew; van den Brink, Wim; de Beaurepaire, Renaud; Leggio, Lorenzo.
Afiliación
  • Agabio R; Department of Biomedical Sciences, Section of Neuroscience and Clinical Pharmacology, University of Cagliari, Cittadella Universitaria, I-09042 Monserrato, Italy. Electronic address: agabio@unica.it.
  • Sinclair JM; Faculty of Medicine, University of Southampton, Southampton, UK.
  • Addolorato G; AUD and Alcohol Related Diseases Unit, Department of Internal Medicine and Gastroenterology, Fondazione Policlinico Universitario A Gemelli Istituto di Ricovero e Cura a Carattere Scientifico, Rome, Italy; Department of Internal Medicine and Gastroenterology, Università Cattolica del Sacro Cuore, Ro
  • Aubin HJ; Centre de Recherche en Epidémiologie et Santé des Populations, Faculté de Médecine, Université Paris-Sud, Paris, France; Faculté de Médecine, Université de Versailles Saint-Quentin-en-Yvelines, Paris, France; Institut National de la Santé et de la Recherche Médicale, Université Paris-Saclay, Paris,
  • Beraha EM; Department of Psychology, University of Amsterdam, Amsterdam, Netherlands.
  • Caputo F; SS Annunziata Hospital, Department of Internal Medicine, Cento, Italy.
  • Chick JD; Castle Craig Hospital, Blyth Bridge, UK; School of Health and Social Care, Edinburgh Napier University, Edinburgh, UK.
  • de La Selle P; Montpellier 34000, France.
  • Franchitto N; Department of Addiction Médicine, Poisons and Substance Abuse Treatment Centre, Toulouse-Purpan University Hospital, Toulouse, France.
  • Garbutt JC; Department of Psychiatry, School of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Haber PS; National Health Medical Research Council, Centre of Research Excellence in Mental Health and Substance Use, Central Clinical School, Sydney Medical School, University of Sydney, Sydney, NSW, Australia; Drug Health Services, Royal Prince Alfred Hospital, Camperdown, NSW, Australia.
  • Heydtmann M; Department of Gastroenterology, Royal Alexandra Hospital Paisley, Paisley, UK.
  • Jaury P; Département de Médecine Générale, Faculté de Médecine, Université Paris Descartes, Paris, France.
  • Lingford-Hughes AR; Neuropsychopharmacology Unit, Centre for Psychiatry, Division of Brain Sciences, Imperial College London, London, UK.
  • Morley KC; Discipline of Addiction Medicine, Faculty of Medicine and Health, University of Sydney, Sydney, Australia.
  • Müller CA; Department of Psychiatry, Campus Charité Mitte, Charité-Universitätsmedizin Berlin, Berlin, Germany.
  • Owens L; Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
  • Pastor A; Department of Addiction Medicine, St Vincent's Hospital Melbourne, Melbourne, Australia; Department of Medicine, University of Melbourne, Melbourne, Australia.
  • Paterson LM; Neuropsychopharmacology Unit, Centre for Psychiatry, Division of Brain Sciences, Imperial College London, London, UK.
  • Pélissier F; Poison Control Centre, Toulouse-Purpan University Hospital, Toulouse, France.
  • Rolland B; Service Universitaire d'Addictologie de Lyon, Lyon, France; University of Lyon, Lyon, France.
  • Stafford A; Royal Perth Hospital, Perth, WA, Australia.
  • Thompson A; Wolfson Centre for Personalised Medicine, University of Liverpool, Liverpool, UK.
  • van den Brink W; Department of Psychiatry, Amsterdam University Medical Centre, Academic Medical Centre, Amsterdam University, Amsterdam, Netherlands.
  • de Beaurepaire R; Groupe Hospitalier Paul-Guiraud, Paris, France.
  • Leggio L; Section on Clinical Psychoneuroendocrinology and Neuropsychopharmacology, National Institute on Alcohol Abuse and Alcoholism, Division of Intramural Clinical and Basic Research and National Institute on Drug Abuse Intramural Research Program, National Institutes of Health, Bethesda, MD, USA; Medicat
Lancet Psychiatry ; 5(12): 957-960, 2018 12.
Article en En | MEDLINE | ID: mdl-30413394
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Baclofeno / Alcoholismo Límite: Humans Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Baclofeno / Alcoholismo Límite: Humans Idioma: En Revista: Lancet Psychiatry Año: 2018 Tipo del documento: Article Pais de publicación: Reino Unido